In a major setback US pharma giant Merck has announced that it will stop making its COVID-19 vaccines after failed clinical trials to generate a strong immune response.
Must Watch: Would you live on 3D Printed Mars for a year for $60,000?
US pharma giant Merck has scrapped two coronavirus vaccine candidates after they failed to produce an adequate immune response in early trials, the company announced Monday.
The results were “disappointing, and a bit of a surprise,” Nick Kartsonis, senior vice president of clinical research for infectious diseases and vaccines at Merck Research Laboratories, told Bloomberg.
The studies haven’t yet been published in a peer-reviewed journal to be scrutinized.
Merck said it would now focus on advancing two experimental treatments for COVID-19 that are in late stage development.
Subscribe to GreatGameIndia
“In the world of pharmaceutical development, a quick kill is not a bad thing because it allows you to reposition and repurpose your assets,” Kartsonis told the Wall Street Journal.
For latest updates on the outbreak check out our Coronavirus Coverage.